Your session is about to expire
← Back to Search
Level 2 for Bipolar Disorder (MoodSwings 2 Trial)
N/A
Waitlist Available
Led By Patricia Suppes, MD, PhD
Research Sponsored by VA Palo Alto Health Care System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes from baseline to 3 months, 6 months,9months and 12 months
Awards & highlights
MoodSwings 2 Trial Summary
The investigators hope to learn whether access to online support and education can help people with Bipolar Disorder (BD) better manage their symptoms of depression.
Eligible Conditions
- Bipolar Disorder
MoodSwings 2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ changes from baseline to 3 months, 6 months,9months and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes from baseline to 3 months, 6 months,9months and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Montgomery Asberg Rating Scale (MADRS) for Depression
Young Mania Rating Scale
Secondary outcome measures
Cornell Service Index (CSI)
Medical Outcomes Study Social Support Survey( MOS-SSS)
Medication Adherence rating Scale( MARS)
+5 moreOther outcome measures
Inventory Of Stigma Experiences
Motivation for Treatment Questionnaire - 8 item ( MTQ 8)
MoodSwings 2 Trial Design
3Treatment groups
Active Control
Group I: Level 2Active Control2 Interventions
Moderated discussion board plus psychoeducation
Group II: Level 3Active Control3 Interventions
Moderated discussion board plus psychoeducation plus interactive psychosocial tools
Group III: Level 1Active Control1 Intervention
Moderated discussion board only
Find a Location
Who is running the clinical trial?
University of MelbourneOTHER
167 Previous Clinical Trials
1,288,000 Total Patients Enrolled
2 Trials studying Bipolar Disorder
700,304 Patients Enrolled for Bipolar Disorder
VA Palo Alto Health Care SystemLead Sponsor
87 Previous Clinical Trials
56,563 Total Patients Enrolled
3 Trials studying Bipolar Disorder
535 Patients Enrolled for Bipolar Disorder
Patricia Suppes, MD, PhDPrincipal InvestigatorVA Palo Alto Health Care System & Stanford University School of Medicine
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger